+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Personalized Medicine Market Size, Share & Trends Analysis Report by Product (Personalized Medical Care, Personalized Nutrition & Wellness, DTC Diagnostics, Telemedicine, Complementary Medicine), and Segment Forecasts, 2021-2028

  • ID: 4827925
  • Report
  • May 2021
  • Region: Global
  • 221 pages
  • Grand View Research

FEATURED COMPANIES

  • 23andME, Inc.
  • bbott Laboratories
  • Danaher
  • GE Healthcare
  • Genentech, Inc.
  • Illumina, Inc.
  • MORE
The global personalized medicine market size is expected to reach USD 796.8 billion by 2028. The market is expected to expand at a CAGR of 6.2% from 2021 to 2028. The market growth can be attributed to several factors such as the high adoption of advanced genome sequencing instruments, the launch of companion diagnostics, and the rising incidence of cancer and other genetic disorders.



In addition, the growing number of retail clinics is further boosting market growth. There is a high adoption rate of telemedicine solutions observed in retail clinics. With the integration of these solutions, retails clinics provide online scheduling solutions to patients along with contactless check-in and payment modes. Hence, such advanced solutions based on telemedicine are contributing to the growth of the market.

Moreover, the robust funding for supporting research on PM and cell therapy is contributing to the market growth. For instance, in May 2020, the Minderoo Foundation and the Federal government granted around USD 67.0 million for the Zero Childhood Cancer program (ZERO). The funding facilitated the development of a comprehensive genomic databank of individual patient’s cancer and healthy cells, facilitating in better understanding of childhood cancer.

Expanding presence of established players in distinct sectors of PM is also set to propel market growth. These are inclusive of companies such as Google and IBM among others. In November 2020, DeepMind, a Google company, announced that made a huge leap in the 3D analysis of proteins from their amino-acid sequence. This is expected to be a revolutionary development in the field of PM diagnostics.

Furthermore, PM is bringing a new paradigm in the ongoing COVID-19 pandemic. With the application of PM, researchers can identify the best management strategies for accurate diagnosis. This in turn will facilitate in designing the therapeutic approaches based on individual COVID-19 patients. However, these medicines are better suited for inherited diseases and conditions such as cancer that are developed owing to genetic mutations rather than infectious diseases.

Personalized Medicine Market Report Highlights

  • The personalized nutrition and wellness segment accounted for the largest revenue share in 2020 owing to the growing demand for products of this segment and less regulatory compliance
  • The expanding pool of operational entities in this segment is expected to boost the sales of personalized nutrition products
  • The therapeutics segment is expected to witness lucrative growth over the forecast period owing to the extensive usage of pharmacogenomics for developing biopharmaceuticals
  • In therapeutics, the genomic medicine segment is expected to witness substantial growth through the forecast period owing to a reduction in costs of whole-genome sequencing
  • North America held the largest revenue share in 2020. The growth of the market in this region is owing to intensive research for the development of new therapies
  • In Asia Pacific, the market is expected to witness the fastest CAGR over the forecast period owing to growing PM startups and favorable government initiatives
  • Companies operating in the market are receiving the U.S. FDA approvals for their personalized medicines. For instance, in February 2021, Biogen Inc. received the U.S. FDA approval for PLEGRIDY (peginterferon beta-1a) for treating patients with relapsing forms of Multiple Sclerosis (MS)

This report will be delivered within 1-3 business days

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 23andME, Inc.
  • bbott Laboratories
  • Danaher
  • GE Healthcare
  • Genentech, Inc.
  • Illumina, Inc.
  • MORE
Chapter 1 Executive Summary
1.1 Personalized Medicine Market Outlook, 2017 - 2028
1.2 Personalized Medicine Market: Segment Outlook, 2017 - 2028

Chapter 2 Research Methodology
2.1 Information Procurement
2.1.1 Purchased database:
2.1.2 Internal Database
2.1.3 Secondary sources:
2.1.4 Third Party Perspective:
2.1.5 Primary Research:
2.2 Data Analysis
2.3 Market Formulation & Validation
2.4 Region Wise Market Calculation
2.4.1 Region wise market: Base estimates
2.4.2 Global market: CAGR calculation
2.4.3 Region based segment share calculation

Chapter 3 Market Variables, Trends& Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Related/ ancillary market outlook
3.2 Penetration & Growth Prospect Mapping for PM Diagnostics & PM Therapeutics, 2020
3.3 Penetration & Growth Prospect Mapping for PM Medical Care & PM Nutrition & Wellness, 2020
3.4 Cost Structure Analysis
3.5 User Perspective Analysis
3.5.1 Consumer behaviour analysis
3.5.2 Market influencer analysis
3.6 Technology Overview
3.6.1 OMICs technology
3.6.1.1 Cross-technology coordination
3.6.1.2 Data management: Analytics, sharing, security, and storage
3.6.2 Sequencing technology
3.6.3 Polymerase Chain Reaction(PCR)
3.6.4 In situ hybridization
3.6.5 Immunohistochemistry
3.6.6 Other technologies
3.7 Regulatory Framework
3.7.1 Reimbursement framework
3.8 Product Pipeline Analysis
3.9 Personalized Medicine Market- Market Dynamics
3.9.1 Market driver analysis
3.9.1.1 Advancements in next generation sequencing technology
3.9.1.2 Expanding portfolio of companion/associated diagnostics
3.9.1.3 Increasing number of retail clinics across the developed regions of North America and Europe
3.9.1.4 Increasing prevalence of cancer & usage of biomarkers for PM cancer therapy
3.9.1.5 Growing healthcare expenditure triggering development of effective PM diagnostic & therapeutic procedure for cancer
3.9.2 Market restraint analysis
3.9.2.1 Lack of proper intellectual property regulations for personalized medical technologies
3.9.2.2 Non-structural development of biomarkers
3.9.3 Market challenge analysis
3.9.3.1 Burden of proof is greater for clinical validation for PM therapeutics
3.10 SWOT By PESTLE Analysis
3.10.1 Political landscape
3.10.2 Economic landscape
3.10.3 Social landscape
3.10.4 Technology landscape
3.11 Industry Analysis - Porter’s
3.11.1 Bargaining power of suppliers: Moderate
3.11.2 Bargaining power of buyers: Moderate
3.11.3 Threat of substitution: Low
3.11.4 Threat of new entrants: Moderate
3.11.5 Competitive rivalry: High
3.12 Market Entry Strategies
3.12.1 Diagnostics companies:
3.12.2 Pharmaceutical and biotechnology companies
3.12.3 Raw material supplier
3.12.4 Distributor
3.12.5 Collaborations between diagnostic and pharma entities
3.13 Personalized Medicine - Application Growth Prospects Analysis
3.13.1 Personalized medicine - Application opportunity v/s implementation
3.13.2 Personalized medicine - Application opportunities prioritized
3.14 COVID-19 Impact on Personalized Medicine Market

Chapter 4 Competitive Analysis
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.2 Company/Competition Categorization
4.3 Vendor Landscape
4.3.1 List of key distributors and channel partners
4.3.2 Key customers
4.4 Key Company Market Share Analysis/Ranking, 2020
4.4.1 Company financial size
4.4.2 Product portfolio
4.4.3 Geographic footprint
4.4.4 Innovation
4.4.5 Pipeline
4.4.6 Strategic initiatives
4.5 Public Companies
4.5.1 Company market position analysis
4.5.1.1 Number of products
4.5.1.2 Market penetration
4.5.1.3 Strategic initiatives
4.5.1.4 Segment coverage
4.5.1.5 Geographical presence
4.5.1.6 Conclusion
4.5.2 Competitive dashboard analysis
4.5.3 Market differentiators
4.5.4 Synergy analysis: Major deals & strategic alliances
4.6 Private Companies
4.6.1 List of key emerging companies
4.6.2 Funding outlook
4.6.3 Regional network map
4.6.4 Company market position analysis
4.6.5 List of suppliers

Chapter 5 Personalized Medicine Market Categorization: Product Estimates & Trend Analysis
5.1 Market: Product Movement Analysis
5.2 Personalized Medicine Diagnostics
5.2.1 Market, 2017 - 2028 (USD Billion)
5.2.2 Genetic testing
5.2.2.1 Market, 2017 - 2028 (USD Billion)
5.2.3 Direct-to-consumer (DTC) diagnostics
5.2.3.1 Market, 2017 - 2028 (USD Billion)
5.2.4 Esoteric lab services
5.2.4.1 Market, 2017 - 2028 (USD Billion)
5.2.5 Esoteric lab tests
5.2.5.1 Market, 2017 - 2028 (USD Billion)
5.3 PM Therapeutics
5.3.1 Market, 2017 - 2028 (USD Billion)
5.3.2 Pharmaceuticals
5.3.2.1 Market, 2017 - 2028 (USD Billion)
5.3.3 Genomic medicine
5.3.3.1 Market, 2017 - 2028 (USD Billion)
5.3.4 Medical devices
5.3.4.1 Market, 2017 - 2028 (USD Billion)
5.4 Personalized Medical Care
5.4.1 Market, 2017 - 2028 (USD Billion)
5.4.2 Telemedicine
5.4.2.1 Global Telemedicine Market, 2017 - 2028 (USD Billion)
5.4.3 Health Information Technology
5.4.3.1 Market, 2017 - 2028 (USD Billion)
5.5 Personalized Nutrition & Wellness
5.5.1 Market, 2017 - 2028 (USD Billion)
5.5.2 Retail Nutrition
5.5.2.1 Market, 2017 - 2028 (USD Billion)
5.5.3 Complementary & Alternative Medicine
5.5.3.1 Market, 2017 - 2028 (USD Billion)

Chapter 6 Personalized Medicine Market Categorization: Regional Estimates & Trend Analysis, by Product
6.1 Market Share by Region, 2018 & 2025
6.2 North America
6.2.1 Market, 2017 - 2028 (USD Billion)
6.2.2 U.S.
6.2.2.1 Market, by product, 2017 - 2028 (USD Billion)
6.2.2.2 Market, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
6.2.2.3 Market, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
6.2.2.4 Market, by personalized medical care, 2017 - 2028 (USD Billion)
6.2.2.5 Market, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
6.2.3 Canada
6.2.3.1 Market, by product, 2017 - 2028 (USD Billion)
6.2.3.2 Market, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
6.2.3.3 Market, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
6.2.3.4 Market, by personalized medical care, 2017 - 2028 (USD Billion)
6.2.3.5 Market, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
6.3 Europe
6.3.1 Market, 2017 - 2028 (USD Billion)
6.3.2 Germany
6.3.2.1 Market, by product, 2017 - 2028 (USD Billion)
6.3.2.2 Market, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
6.3.2.3 Market, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
6.3.2.4 Market, by personalized medical care, 2017 - 2028 (USD Billion)
6.3.2.5 Market, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
6.3.3 U.K.
6.3.3.1 Market, by product, 2017 - 2028 (USD Billion)
6.3.3.2 Market, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
6.3.3.3 Market, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
6.3.3.4 Market, by personalized medical care, 2017 - 2028 (USD Billion)
6.3.3.5 Market, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
6.3.4 Italy
6.3.4.1 Market, by product, 2017 - 2028 (USD Billion)
6.3.4.2 Market, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
6.3.4.3 Market, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
6.3.4.4 Market, by personalized medical care, 2017 - 2028 (USD Billion)
6.3.4.5 Market, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
6.3.5 France
6.3.5.1 Market, by product, 2017 - 2028 (USD Billion)
6.3.5.2 Market, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
6.3.5.3 Market, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
6.3.5.4 Market, by personalized medical care, 2017 - 2028 (USD Billion)
6.3.5.5 Market, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
6.4 Asia Pacific
6.4.1 Market, 2017 - 2028 (USD Billion)
6.4.2 Japan
6.4.2.1 Market, by product, 2017 - 2028 (USD Billion)
6.4.2.2 Market, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
6.4.2.3 Market, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
6.4.2.4 Market, by personalized medical care, 2017 - 2028 (USD Billion)
6.4.2.5 Market, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
6.4.3 China
6.4.3.1 Market, by product, 2017 - 2028 (USD Billion)
6.4.3.2 Market, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
6.4.3.3 Market, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
6.4.3.4 Market, by personalized medical care, 2017 - 2028 (USD Billion)
6.4.3.5 Market, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
6.4.4 India
6.4.4.1 Market, by product, 2017 - 2028 (USD Billion)
6.4.4.2 Market, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
6.4.4.3 Market, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
6.4.4.4 Market, by personalized medical care, 2017 - 2028 (USD Billion)
6.4.4.5 Market, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
6.4.5 South Korea
6.4.5.1 Market, by product, 2017 - 2028 (USD Billion)
6.4.5.2 Market, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
6.4.5.3 Market, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
6.4.5.4 Market, by personalized medical care, 2017 - 2028 (USD Billion)
6.4.5.5 Market, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
6.5 Latin America
6.5.1 Market, 2017 - 2028 (USD Billion)
6.5.2 Brazil
6.5.2.1 Market, by product, 2017 - 2028 (USD Billion)
6.5.2.2 Market, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
6.5.2.3 Market, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
6.5.2.4 Market, by personalized medical care, 2017 - 2028 (USD Billion)
6.5.2.5 Market, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
6.5.3 Mexico
6.5.3.1 Market, by product, 2017 - 2028 (USD Billion)
6.5.3.2 Market, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
6.5.3.3 Market, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
6.5.3.4 Market, by personalized medical care, 2017 - 2028 (USD Billion)
6.5.3.5 Market, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
6.6 Middle East & Africa
6.6.1 Market, 2017 - 2028 (USD Billion)
6.6.2 South Africa
6.6.2.1 Market, by product, 2017 - 2028 (USD Billion)
6.6.2.2 Market, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
6.6.2.3 Market, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
6.6.2.4 Market, by personalized medical care, 2017 - 2028 (USD Billion)
6.6.2.5 Market, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
6.6.3 Saudi Arabia
6.6.3.1 Market, by product, 2017 - 2028 (USD Billion)
6.6.3.2 Market, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
6.6.3.3 Market, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
6.6.3.4 Market, by personalized medical care, 2017 - 2028 (USD Billion)
6.6.3.5 Market, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)

Chapter 7 Competitive Landscape
7.1 Strategy Framework
7.2 Market Participation Categorization
7.3 Company Profiles
7.3.1 GE Healthcare
7.3.1.1 Company overview
7.3.1.2 Financial performance
7.3.1.3 Product Benchmarking
7.3.1.4 Strategic initiatives
7.3.2 Illumina, Inc.
7.3.2.1 Company overview
7.3.2.2 Financial performance
7.3.2.3 Product benchmarking
7.3.2.4 Strategic initiatives
7.3.3 ASURAGEN, INC.
7.3.3.1 Company overview
7.3.3.2 Product benchmarking
7.3.3.3 Strategic initiatives
7.3.4 Danaher
7.3.4.1 Company overview
7.3.4.2 Cepheid
7.3.4.2.1 Company overview
7.3.4.3 Financial performance
7.3.4.4 Product benchmarking
7.3.4.5 Strategic initiatives
7.3.5 Abbott Laboratories
7.3.5.1 Company overview
7.3.5.2 Financial performance
7.3.5.3 Product benchmarking
7.3.5.4 Strategic Initiatives
7.3.6 Exact Sciences Corporation
7.3.6.1 Company overview
7.3.6.2 Financial performance
7.3.6.3 Product benchmarking
7.3.6.4 Strategic initiatives
7.3.7 Biogen International
7.3.7.1 Company overview
7.3.7.2 Financial performance
7.3.7.3 Product benchmarking
7.3.7.4 Strategic initiatives
7.3.8 Exagen Inc.
7.3.8.1 Company overview
7.3.8.2 Product benchmarking
7.3.8.3 Strategic initiatives
7.3.9 Genelex Corporation
7.3.9.1 Company overview
7.3.9.2 Product benchmarking
7.3.9.3 Strategic initiatives
7.3.10 Precision Biologics, Inc.
7.3.10.1 Company overview
7.3.10.2 Product benchmarking
7.3.10.3 Strategic initiatives
7.3.11 QIAGEN
7.3.11.1 Company overview
7.3.11.2 Financial performance
7.3.11.3 Product benchmarking
7.3.11.4 Strategic initiatives
7.3.12 IBM
7.3.12.1 Company overview
7.3.12.2 Financial performance
7.3.12.3 Product benchmarking
7.3.12.4 Strategic initiatives
7.3.13 Genentech, Inc.
7.3.13.1 Company overview
7.3.13.2 Financial performance
7.3.13.3 Product benchmarking
7.3.13.4 Strategic initiatives
7.3.14 23andME, Inc.
7.3.14.1 Company overview
7.3.14.2 Financial performance
7.3.14.3 Product benchmarking
7.3.14.4 Strategic initiatives

List of Tables
Table 1 Country share estimation
Table 2 FDA-approved and CE-marked tests with an epigenetic component
Table 3 Pipeline program of Cellworks
Table 4 List of distributors and channel partners
Table 5 List of emerging companies
Table 6 List of suppliers
Table 7 Healthcare expenditure levels, 2020
Table 8 North America personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
Table 9 North America market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
Table 10 North America market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
Table 11 North America market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
Table 12 North America market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
Table 13 U.S. personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
Table 14 U.S. market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
Table 15 U.S. market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
Table 16 U.S. market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
Table 17 U.S. market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
Table 18 Canada personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
Table 19 Canada market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
Table 20 Canada market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
Table 21 Canada market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
Table 22 Canada market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
Table 23 Europe personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
Table 24 Europe market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
Table 25 Europe market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
Table 26 Europe market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
Table 27 Europe market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
Table 28 Germany personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
Table 29 Germany market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
Table 30 Germany market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
Table 31 Germany market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
Table 32 Germany market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
Table 33 U.K. personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
Table 34 U.K. market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
Table 35 U.K. market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
Table 36 U.K. market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
Table 37 U.K. market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
Table 38 Italy personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
Table 39 Italy market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
Table 40 Italy market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
Table 41 Italy market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
Table 42 Italy market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
Table 43 France personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
Table 44 France market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
Table 45 France market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
Table 46 France market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
Table 47 France market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
Table 48 Asia Pacific personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
Table 49 Asia Pacific market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
Table 50 Asia Pacific market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
Table 51 Asia Pacific market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
Table 52 Asia Pacific market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
Table 53 Japan personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
Table 54 Japan market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
Table 55 Japan market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
Table 56 Japan market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
Table 57 Japan market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
Table 58 China personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
Table 59 China market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
Table 60 China market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
Table 61 China market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
Table 62 China market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
Table 63 India personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
Table 64 India market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
Table 65 India market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
Table 66 India market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
Table 67 India market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
Table 68 South Korea personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
Table 69 South Korea market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
Table 70 South Korea market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
Table 71 South Korea market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
Table 72 South Korea market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
Table 73 Latin America personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
Table 74 Latin America market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
Table 75 Latin America market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
Table 76 Latin America market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
Table 77 Latin America market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
Table 78 Brazil personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
Table 79 Brazil market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
Table 80 Brazil market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
Table 81 Brazil market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
Table 82 Brazil market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
Table 83 Mexico personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
Table 84 Mexico market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
Table 85 Mexico market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
Table 86 Mexico market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
Table 87 Mexico market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
Table 88 MEA personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
Table 89 MEA market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
Table 90 MEA market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
Table 91 MEA market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
Table 92 MEA market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
Table 93 South Africa personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
Table 94 South Africa market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
Table 95 South Africa market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
Table 96 South Africa market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
Table 97 South Africa market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)
Table 98 Saudi Arabia personalized medicine market estimates & forecasts, by product, 2017 - 2028 (USD Billion)
Table 99 Saudi Arabia market estimates & forecasts, by personalized medicine diagnostics, 2017 - 2028 (USD Billion)
Table 100 Saudi Arabia market estimates & forecasts, by personalized medicine therapeutics, 2017 - 2028 (USD Billion)
Table 101 Saudi Arabia market estimates & forecasts, by personalized medical care, 2017 - 2028 (USD Billion)
Table 102 Saudi Arabia market estimates & forecasts, by personalized nutrition & wellness, 2017 - 2028 (USD Billion)

List of Figures
Fig. 1 Market segmentation & scope
FIG. 2 Market summary
FIG. 3 Market research process
FIG. 4 Information procurement
FIG. 5 Primary research pattern
FIG. 6 Market research approaches
FIG. 7 Value chain-based sizing & forecasting
FIG. 8 QFD modelling for market share assessment
FIG. 9 Parent market outlook
FIG. 10 Penetration & growth prospect mapping for PM diagnostics & PM therapeutics, 2020
FIG. 11 Penetration & growth prospect mapping for PM medical care & PM nutrition & wellness, 2020
FIG. 12 Consumer awareness of personalized medicine
FIG. 13 PCR-based platforms for mutation detection
FIG. 14 Companion diagnostics pipeline, as of March 2020
FIG. 15 Market trends & outlook
FIG. 16 Market driver relevance analysis (Current & future impact)
FIG. 17 DNA sequencing cost per genome
FIG. 18 Global cancer incidence, as of September 2020
FIG. 19 Use of cancer biomarkers in cancer management
FIG. 20 Expected rise in expenditure for cancer treatment (USD Billion)
FIG. 21 Growth in number of personalized medicines available in the U.S. from 2008 to 2020
FIG. 22 Market restraint relevance analysis (Current & future impact)
FIG. 23 Business models for market entry
FIG. 24 Marketing channels
FIG. 25 Personalized medicine - application opportunity v/s implementation
FIG. 26 Personalized medicine - Application opportunities prioritized
FIG. 27 Impact analysis by key companies
FIG. 28 Company categorization
FIG. 29 Heat map analysis of top key players, 2020
FIG. 30 Public companies market position analysis
FIG. 31 Competitive dashboard analysis for public players
FIG. 32 Regional network map for private players
FIG. 33 Personalized medicine market: Product outlook key takeaways
FIG. 34 Personalized medicine market: Product movement analysis
FIG. 35 Global personalized medicine diagnostics market, 2017 - 2028 (USD Billion)
FIG. 36 Global genetic testing market, 2017 - 2028 (USD Billion)
FIG. 37 Global DTC diagnostics market, 2017 - 2028 (USD Billion)
FIG. 38 Global esoteric lab services market, 2017 - 2028 (USD Billion)
FIG. 39 Global esoteric lab tests market, 2017 - 2028 (USD Billion)
FIG. 40 Global personalized medicine therapeutics market, 2017 - 2028 (USD Billion)
FIG. 41 Global pharmaceuticals market, 2017 - 2028 (USD Billion)
FIG. 42 Global genomic medicine market, 2017 - 2028 (USD Billion)
FIG. 43 Global medical devices market, 2017 - 2028 (USD Billion)
FIG. 44 Global personalized medical care market, 2017 - 2028 (USD Billion)
FIG. 45 Global telemedicine market, 2017 - 2028 (USD Billion)
FIG. 46 Global health information technology market, 2017 - 2028 (USD Billion)
FIG. 47 Global personalized nutrition & wellness market, 2017 - 2028 (USD Billion)
FIG. 48 Global retail nutrition market, 2017 - 2028 (USD Billion)
FIG. 49 Global complementary & alternative medicine market, 2017 - 2028 (USD Billion)
FIG. 50 Regional market place: Key takeaway
FIG. 51 Personalized medicine regional outlook, 2020 & 2028
FIG. 52 North America personalized medicine market, 2017 - 2028 (USD Billion)
FIG. 53 U.S. personalized medicine market, 2017 - 2028 (USD Billion)
FIG. 54 Canada personalized medicine market, 2017 - 2028 (USD Billion)
FIG. 55 Europe personalized medicine market, 2017 - 2028 (USD Billion)
FIG. 56 Germany personalized medicine market, 2017 - 2028 (USD Billion)
FIG. 57 U.K. personalized medicine market, 2017 - 2028 (USD Billion)
FIG. 58 Italy personalized medicine market, 2017 - 2028 (USD Billion)
FIG. 59 France personalized medicine market, 2017 - 2028 (USD Billion)
FIG. 60 Asia Pacific personalized medicine market, 2017 - 2028 (USD Billion)
FIG. 61 Japan personalized medicine market, 2017 - 2028 (USD Billion)
FIG. 62 China personalized medicine market, 2017 - 2028 (USD Billion)
FIG. 63 India personalized medicine market, 2017 - 2028 (USD Billion)
FIG. 64 South Korea personalized medicine market, 2017 - 2028 (USD Billion)
FIG. 65 Latin America personalized medicine market, 2017 - 2028 (USD Billion)
FIG. 66 Brazil personalized medicine market, 2017 - 2028 (USD Billion)
FIG. 67 Mexico personalized medicine market, 2017 - 2028 (USD Billion)
FIG. 68 Middle East & Africa personalized medicine market, 2017 - 2028 (USD Billion)
FIG. 69 South Africa personalized medicine market, 2017 - 2028 (USD Billion)
FIG. 70 Saudi Arabia personalized medicine market, 2017 - 2028 (USD Billion)
FIG. 71 Strategy framework
FIG. 72 Participant categorization
Note: Product cover images may vary from those shown
  • GE Healthcare
  • Illumina, Inc.
  • ASURAGEN, INC.
  • Danaher
  • bbott Laboratories
  • Exact Sciences Corporation
  • Biogen International
  • Exagen Inc.
  • Genelex Corporation
  • Precision Biologics, Inc.
  • QIAGEN
  • IBM
  • Genentech, Inc.
  • 23andME, Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll